PACT Trademark

Trademark Overview

On Saturday, November 9, 2019, a trademark application was filed for PACT with the United States Patent and Trademark Office. The USPTO has given the PACT trademark a serial number of 88686158. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Thursday, November 23, 2023. This trademark is owned by PACT Pharma, Inc.. The PACT trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
pact

General Information

Serial Number88686158
Word MarkPACT
Filing DateSaturday, November 9, 2019
Status711 - CANCELLED - SECTION 7
Status DateThursday, November 23, 2023
Registration Number6451318
Registration DateTuesday, August 17, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements

Goods and ServicesBio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
Description of MarkThe mark consists of the word "PACT" having the letter "T" split vertically.
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateThursday, November 23, 2023
Primary Code040
First Use Anywhere DateMonday, May 1, 2017
First Use In Commerce DateMonday, May 1, 2017

Trademark Owner History

Party NamePACT Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePACT Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePACT Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Thursday, November 23, 2023CANCELLED SECTION 7-TOTAL
Wednesday, November 8, 2023NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Friday, June 16, 2023REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Friday, June 16, 2023REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Friday, June 16, 2023REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Tuesday, November 7, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 16, 2023TEAS SECTION 7 SURRENDER RECEIVED
Tuesday, August 17, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 24, 2021EXAMINER'S AMENDMENT ENTERED
Saturday, April 24, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, April 24, 2021EXAMINERS AMENDMENT E-MAILED
Saturday, April 24, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, April 23, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, April 13, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, February 10, 2021NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, February 10, 2021ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, February 10, 2021ACTION CONTINUING FINAL - COMPLETED
Tuesday, January 19, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 19, 2021EX PARTE APPEAL-INSTITUTED
Tuesday, January 19, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, January 19, 2021EXPARTE APPEAL RECEIVED AT TTAB
Saturday, July 18, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, July 18, 2020FINAL REFUSAL E-MAILED
Saturday, July 18, 2020FINAL REFUSAL WRITTEN
Wednesday, July 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION WRITTEN
Thursday, February 13, 2020ASSIGNED TO EXAMINER
Saturday, November 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 13, 2019NEW APPLICATION ENTERED

Related Keywords

pact management manufacturing adoptive cell self misuse substance pain patient none